Floatz logo

Cotrimoxazole

Urinary Tract Infections

Indonesia UniversityPhase 2Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
31/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Urinary Tract Infections cohort.

Asset / SponsorPhaseRating
NORMAL HUMAN SERUM ALBUMIN
EASL - CLIF Consortium
Phase 4BB
Cranberry
Rennes University Hospital
Phase 3B
Allocetra-Ots
Enlivex Therapeutics Ltd.
Phase 2CCC
Gentamycin
Medstar Health Research Institute
Early Phase 1C
Lactobacillus Rhamnosus Gg
Medstar Health Research Institute
Early Phase 1C

View all 9 →

Same molecule, other indications

Cotrimoxazole is also rated in:

Life-threatening InfectionDormant
CCC
Indicative ·
52 / 100
View asset →
Nutrition DisordersDormant
CCC
Indicative ·
52 / 100
View asset →
peritonitisDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →